Troponins in acute coronary syndromes: More TACTICS for an early invasive strategy

JAMA

Volumn 286, Issue 19, 2001, Pages 2461-2462

  Quinn, M J ^a   Moliterno, D J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN; TROPONIN I; TROPONIN T;

ACUTE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG COST; EDITORIAL; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; MEDICAL DECISION MAKING; PRIORITY JOURNAL;

EID: 0035930055     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.19.2461     Document Type: Editorial

References (21)

1. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis
2. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
3. Angiographic findings in patients with refractory unstable angina according to troponin T status
4. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: The paragon-B troponin T substudy
5. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
6. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
7. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection
8. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction
9. Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure
10. Quantitative bedside assay for cardiac troponin T
11. Comparison of immunoreactivity of five human cardiac troponin I assays toward free and complexed forms of the antigen: Implications for assay discordance
12. Myocardial infarction redefined
13. Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay
14. Lower cardiac troponin T and I results in heparin-plasma than in serum
15. Elevation of troponin I in sepsis and septic shock
16. False increase of cardiac troponin I with heterophilic antibodies
17. Cardiac troponin T and I in end-stage renal failure
18. Cardiac troponin T predicts mortality in patients with end-stage renal disease
19. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism
20. Circulating cardiac troponin I in acute pericarditis
21. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcome